“…62 (s, 3H) [4,5]isothiazolo [2,3-a]furo [2,3- [4,5]isothiazolo [2,3-a]furo [2,3- [4,5]isothiazolo [2,3-a]furo [2,3-e] pyridine -2(11aH)-one 10,10-dioxide (5a) was obtained in 60% yield; the enantiomeric excess was determined to be 55% by HPLC analysis on Daicel Chiralcel IE column (40% 2-propanol/n-hexane, 1 mL/min, temperature 35 °C), UV 285 nm, tmajor = 20.97 min, tminor = 28.28 min. (3aS,4S,11aS)-3a-Methyl-4-(p-tolyl)-3a,4-dihydro-1H-benzo [4,5]isothiazolo [2,3-a]furo [2,3- [4,5]isothiazolo [2,3-a]furo [2,3- [4,5]isothiazolo [2,3-a]furo [2,3-e] pyridin-2(11aH)-one 10,10-dioxide (5d) was obtained in 34% yield; the enantiomeric excess was determined to be 63% by HPLC analysis on Daicel Chiralcel IA column (10% 2-propanol/n-hexane, 1 mL/min, temperature 35 °C), UV 285 nm, tminor = 57.94 min, tmajor = 73.67 min. [4,5]isothiazolo [2,3-a]furo [2,3- (3aS,12R,12aS)-8-Bromo-12a-methyl-12-phenyl-3,3a,12,12a-tetrahydro-2H-benzo[e]furo [2ʹ,3ʹ:5,6] pyrido [1,2-c] [1,2,3]oxathiazin-2-one 5,5-dioxide (8b) was obtained in 45% yield; the enantiomeric excess was determined to be >99% by HPLC analysis on Daicel Chiralcel IA column (40% 2-propanol/n-hexane, 1 mL/min, temperature 35 °C), UV 285 nm, tmajor = 6.28 min, tminor = 8.00 min.…”